Allakos Inc. - stock earnings

ALLK Quarterly earnings

DateEarningsRevenue
2023Q3 -45.6 million USD ? USD
2023Q2 -35.1 million USD ? USD
2023Q1 -39.8 million USD ? USD
2022Q4 -39.8 million USD ? USD
2022Q3 -30.2 million USD ? USD
2022Q2 -49.1 million USD ? USD
2022Q1 -198.4 million USD ? USD
2021Q4 -94.4 million USD ? USD
2021Q3 -62.7 million USD ? USD
2021Q2 -57.2 million USD ? USD
2021Q1 -55.6 million USD ? USD
2020Q4 -44.3 million USD ? USD
2020Q3 -42.1 million USD ? USD
2020Q2 -39.3 million USD ? USD
2020Q1 -26.0 million USD ? USD
2019Q4 -24.6 million USD ? USD
2019Q3 -21.7 million USD ? USD
2019Q2 -19.0 million USD ? USD
2019Q1 -20.0 million USD ? USD
2018Q4 -14.5 million USD ? USD
2018Q3 -11.1 million USD ? USD
2018Q2 -9.4 million USD ? USD
2018Q1 -8.5 million USD ? USD
2017Q4 -7.9 million USD ? USD
2017Q3 -5.9 million USD ? USD
2017Q2 -4.7 million USD ? USD
2017Q1 -5.1 million USD ? USD
2016Q4 -17.1 million USD ? USD

ALLK Yearly earnings

DateEarningsRevenue
2023 -166.1 million USD ? USD
2022 -317.5 million USD ? USD
2021 -267.2 million USD ? USD
2020 -147.6 million USD ? USD
2019 -77.7 million USD ? USD
2018 -43.5 million USD ? USD
2017 -23.6 million USD ? USD
2016 -17.1 million USD ? USD

ALLK

Price: $1.10

52 week price:
1.00
5.64

Earnings Per Share: -2.14 USD

P/E Ratio: -0.80

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 140771

Market Capitalization: 105.4 million

Links: